NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









ValoHealth

ValoHealth

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.valohealth.com

Last Round

SPAC Merger

Nov 15, 2021

Est. Valuation

$2.8B

Total Funding Raised

$590M

Company Overview

Valo is a health technology company that offers a platform leveraging machine learning and cloud computing to streamline the drug discovery and development process by analyzing human data to identify novel links between genetic markers and diseases, thereby assisting healthcare clients in developing treatments for oncology, neurodegenerative, and cardiovascular conditions.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

AI drug discoverytechbiodrug discovery platformcomputational drug discoverytherapeutics developmenthuman-centric datain silico drug discoveryreal-world datadrug target identificationpharmaceutical partnershipsprecision medicinemolecule designcardiovascular diseaseoncologyneurodegenerative disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ValoHealth Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ValoHealth Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SPAC MergerNov 15, 2021
SPAC Merger / PIPEJun 9, 2021
Series BMar 9, 2021
Series BJan 11, 2021
Series ASep 24, 2020

Key People

Founding team and executive leadership

Brian Alexander

Chief Executive Officer

Executive Team

Brett Blackman

Chief Innovation Officer, Head Of Corporate Business Development, Chief Operating Officer

Executive Team

ValoHealth Investors

Notable investors and investment history

InvestorRounds
Khosla VenturesSPAC Merger / PIPE, SPAC Merger, Series B
MissionBlue Capital PartnersSeries B
Longevity Vision FundSPAC Merger / PIPE, SPAC Merger
Public Sector Pension Investment BoardSPAC Merger / PIPE, SPAC Merger, Series B
CAZ InvestmentsSPAC Merger / PIPE, SPAC Merger
State of Michigan Retirement SystemSPAC Merger / PIPE, SPAC Merger
Mirae Asset CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Karin Conde-Knape appointed as the new Chief Scientific Officer.

  • Dec 2, 2025

    Rita Kale appointed as Chief Financial Officer.

ValoHealth Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ValoHealth Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ValoHealth's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range202
Year Founded2019
Last FundingNov 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.